{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:15:34Z","timestamp":1792671334852,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Many patients with axial spondyloarthritis (axSpA) report persistent pain even when treated with anti-inflammatory agents. Our aim was to explore the presence of central sensitization (CS) and different types of illness perceptions in patients with axSpA, and to assess their associations with disease activity assessments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Consecutive outpatients from the Groningen Leeuwarden Axial Spondyloarthritis (GLAS) cohort were included. Besides standardized assessments, patients filled out the Central Sensitization Inventory (CSI), Illness Perception Questionnaire (IPQ-R) and Pain Catastrophizing Scale (PCS). Univariable and multivariable linear regression analyses were used to investigate the association between questionnaire scores, patient characteristics and disease activity assessments ASDASCRP, BASDAI and CRP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 182 patients with a mean symptom duration of 21.6\u2009years. Mean ASDASCRP was 2.1, mean BASDAI 3.9, and median CRP 2.9. Mean CSI score was 37.8 (scale 0\u2013100) and 45% of patients scored \u226540, indicating a high probability of CS. CSI score, IPQ-R domain identity (number of symptoms the patient attributes to their illness), and IPQ-R domain treatment control (perceived treatment efficacy), and obesity were significantly and independently associated with both ASDASCRP and BASDAI, explaining a substantial proportion of variation in these disease activity scores (R2=0.35 and R2=0.47, respectively). Only obesity was also independently associated with CRP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CS may be common in patients with long-term axSpA. CS, as well as specific illness perceptions and obesity were all independently associated with the widely used (partially) patient-reported disease activity assessments ASDASCRP and BASDAI. Treating physicians should take this into account in the follow-up and treatment of their patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab019","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T20:14:02Z","timestamp":1611087242000},"page":"4476-4485","source":"Crossref","is-referenced-by-count":58,"title":["Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-3761","authenticated-orcid":false,"given":"Stan C","family":"Kieskamp","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Paap","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology and Department of Rehabilitation Medicine, University Medical Centre Groningen, Groningen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies J G","family":"Carbo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freke","family":"Wink","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Arends","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology"},{"name":"Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Spoorenberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology"},{"name":"Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2021100217423486200_keab019-B1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.semarthrit.2014.10.009","article-title":"The burden of non-radiographic axial spondyloarthritis","volume":"44","author":"Boonen","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2021100217423486200_keab019-B2","first-page":"S108","article-title":"Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis","volume":"27","author":"Kiltz","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2021100217423486200_keab019-B3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/rheumatology\/kes066","article-title":"First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis","volume":"51","author":"van den Berg","year":"2012","journal-title":"Rheumatology"},{"key":"2021100217423486200_keab019-B4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021100217423486200_keab019-B5","first-page":"61","article-title":"Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice","volume":"35","author":"Arends","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2021100217423486200_keab019-B6","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00296-013-2772-6","article-title":"Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis","volume":"33","author":"Machado","year":"2013","journal-title":"Rheumatol Int"},{"key":"2021100217423486200_keab019-B7","first-page":"CD005468","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","volume":"4","author":"Maxwell","year":"2015","journal-title":"Cochrane Database Syst. Rev"},{"key":"2021100217423486200_keab019-B8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/1744666X.2019.1561281","article-title":"The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond","volume":"15","author":"Dubash","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2021100217423486200_keab019-B9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychores.2018.12.010","article-title":"Central sensitization in chronic pain and medically unexplained symptom research: a systematic review of definitions, operationalizations and measurement instruments","volume":"117","author":"Den Boer","year":"2019","journal-title":"J Psychosom Res"},{"key":"2021100217423486200_keab019-B10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2008.04.025","article-title":"The Kyoto protocol of IASP Basic Pain Terminology","volume":"137","author":"Loeser","year":"2008","journal-title":"Pain"},{"key":"2021100217423486200_keab019-B11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1533-2500.2011.00493.x","article-title":"The development and psychometric validation of the central sensitization inventory","volume":"12","author":"Mayer","year":"2012","journal-title":"Pain Pract"},{"key":"2021100217423486200_keab019-B12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.semarthrit.2011.08.001","article-title":"Central sensitization in patients with rheumatoid arthritis: a systematic literature review","volume":"41","author":"Meeus","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2021100217423486200_keab019-B13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-019-04749-1","article-title":"The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases","volume":"39","author":"Guler","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2021100217423486200_keab019-B14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/ejp.1432","article-title":"A diagnosis of rheumatoid arthritis, endometriosis or IBD is associated with later onset of fibromyalgia and chronic widespread pain","volume":"23","author":"Larrosa Pardo","year":"2019","journal-title":"Eur J Pain"},{"key":"2021100217423486200_keab019-B15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","article-title":"Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives","volume":"44","author":"Spoorenberg","year":"2005","journal-title":"Rheumatology"},{"key":"2021100217423486200_keab019-B16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.23339","article-title":"Pain catastrophizing, subjective outcomes, and inflammatory assessments including ultrasound: results from a longitudinal study of rheumatoid arthritis patients","volume":"70","author":"Hammer","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2021100217423486200_keab019-B17","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar3369","article-title":"Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study","volume":"13","author":"Arends","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021100217423486200_keab019-B18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021100217423486200_keab019-B19","volume-title":"International standard classification of education (ISCED) 2011","year":"2012"},{"key":"2021100217423486200_keab019-B20","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021100217423486200_keab019-B21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The Pain Catastrophizing Scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"key":"2021100217423486200_keab019-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870440290001494","article-title":"The Revised Illness Perception Questionnaire (IPQ-R)","volume":"17","author":"Moss-Morris","year":"2002","journal-title":"Psychol Health"},{"key":"2021100217423486200_keab019-B23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.11.012","article-title":"The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample","volume":"14","author":"Neblett","year":"2013","journal-title":"J Pain"},{"key":"2021100217423486200_keab019-B24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13075-016-1200-1","article-title":"Serum biomarkers and changes in clinical\/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study","volume":"18","author":"Inman","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021100217423486200_keab019-B25","doi-asserted-by":"crossref","first-page":"e12119","DOI":"10.1111\/jabr.12119","article-title":"Convergent validity and clinically relevant categories for the Dutch Central Sensitization Inventory in patients with chronic pain","volume":"23","author":"van der Noord","year":"2018","journal-title":"J Appl Biobehav Res"},{"key":"2021100217423486200_keab019-B26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jmpt.2017.08.007","article-title":"Association between symptoms of central sensitization and cognitive behavioral factors in people with chronic nonspecific low back pain: a cross-sectional study","volume":"41","author":"Huysmans","year":"2018","journal-title":"J Manipulative Physiol Ther"},{"key":"2021100217423486200_keab019-B27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/AJP.0000000000000306","article-title":"The Dutch Central Sensitization Inventory (CSI): factor analysis, discriminative power, and test-retest reliability","volume":"32","author":"Kregel","year":"2016","journal-title":"Clin J Pain"},{"key":"2021100217423486200_keab019-B28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","article-title":"A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population","volume":"157","author":"Mansfield","year":"2016","journal-title":"Pain"},{"key":"2021100217423486200_keab019-B29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kex318","article-title":"Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis","volume":"57","author":"Baraliakos","year":"2018","journal-title":"Rheumatology"},{"key":"2021100217423486200_keab019-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2018.00035","article-title":"Potential mechanisms underlying centralized pain and emerging therapeutic interventions","volume":"12","author":"Eller-Smith","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"2021100217423486200_keab019-B31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.semarthrit.2011.08.001","article-title":"Central sensitization in patients with rheumatoid arthritis: a systematic literature review","volume":"41","author":"Meeus","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2021100217423486200_keab019-B32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-019-2042-4","article-title":"Association between pain phenotype and disease ativity in rheumatoid arthritis patients: a non-interventional, longitudinal cohort study","volume":"21","author":"ten Klooster","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2021100217423486200_keab019-B33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/306686a0","article-title":"Evidence for a central component of post-injury pain hypersensitivity","volume":"306","author":"Woolf","year":"1983","journal-title":"Nature"},{"key":"2021100217423486200_keab019-B34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.anes.0000264769.87038.55","article-title":"Central sensitization: uncovering the relation between pain and plasticity","volume":"106","author":"Woolf","year":"2007","journal-title":"Anesthesiology"},{"key":"2021100217423486200_keab019-B35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(93)90183-P","article-title":"Afferent and spinal mechanisms of joint pain","volume":"55","author":"Schaible","year":"1993","journal-title":"Pain"},{"key":"2021100217423486200_keab019-B36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1467-9450.00276","article-title":"Cognitive-emotional sensitization and somatic health complaints","volume":"43","author":"Brosschot","year":"2002","journal-title":"Scand J Psychol"},{"key":"2021100217423486200_keab019-B37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2522\/ptj.20100330","article-title":"Impact of psychological factors in the experience of pain","volume":"91","author":"Linton","year":"2011","journal-title":"Phys Ther"},{"key":"2021100217423486200_keab019-B38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/AJP.0b013e3182385392","article-title":"Fear-avoidance model of chronic pain: the next generation","volume":"28","author":"Crombez","year":"2012","journal-title":"Clin J Pain"},{"key":"2021100217423486200_keab019-B39","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1037\/0022-006X.67.6.931","article-title":"Chronic low-back pain: what does cognitive coping skills training add to operant behavioral treatment? Results of a randomized clinical trial","volume":"67","author":"Kole-Snijders","year":"1999","journal-title":"J Consult Clin Psychol"},{"key":"2021100217423486200_keab019-B40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/npp.2010.81","article-title":"How placebos change the patient\u2019s brain","volume":"36","author":"Benedetti","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2021100217423486200_keab019-B41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3899\/jrheum.150648","article-title":"Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome","volume":"43","author":"Maas","year":"2016","journal-title":"J Rheumatol"},{"key":"2021100217423486200_keab019-B42","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021100217423486200_keab019-B43","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/rheumatology\/kev119","article-title":"Male and female patients with axial spondyloarthritis experience disease activity, physical function and quality of life differently: results from the Groningen Leeuwarden Axial Spondyloarthritis cohort","volume":"54","author":"Arends","year":"2015","journal-title":"Rheumatology"},{"key":"2021100217423486200_keab019-B44","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.semarthrit.2018.07.015","article-title":"Although female patients with ankylosing spondylitis score worse on disease activity than male patients and improvement in disease activity is comparable, male patients show more radiographic progression during treatment with TNF-\u03b1 inhibitors","volume":"48","author":"van der Slik","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2021100217423486200_keab019-B45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002508-199903000-00006","article-title":"Does gender affect appraisal of pain and pain coping strategies?","volume":"15","author":"Unruh","year":"1999","journal-title":"Clin J Pain"},{"key":"2021100217423486200_keab019-B46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejpain.2004.01.003","article-title":"Sex differences in pain and analgesia: the role of gonadal hormones","volume":"8","author":"Craft","year":"2004","journal-title":"Eur J Pain"},{"key":"2021100217423486200_keab019-B47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jpain.2005.10.013","article-title":"Gender differences in pain and secondary hyperalgesia after heat\/capsaicin sensitization in healthy volunteers","volume":"7","author":"Jensen","year":"2006","journal-title":"J Pain"},{"key":"2021100217423486200_keab019-B48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/j.pain.0000000000001389","article-title":"The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain","volume":"160","author":"Perrot","year":"2019","journal-title":"Pain"},{"key":"2021100217423486200_keab019-B49","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/14656566.2019.1647166","article-title":"Treatment of central sensitization in patients with chronic pain: time for change?","volume":"20","author":"Nijs","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"2021100217423486200_keab019-B50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpain.2009.02.002","article-title":"Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera","volume":"10","author":"Arendt-Nielsen","year":"2009","journal-title":"J Pain"},{"key":"2021100217423486200_keab019-B51","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/01.j.pain.0000460343.46847.58","article-title":"Role of endogenous pain modulation in chronic pain mechanisms and treatment","volume":"156","author":"Yarnitsky","year":"2015","journal-title":"Pain"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab019\/36105121\/keab019.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/10\/4476\/40500294\/keab019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/10\/4476\/40500294\/keab019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T17:46:54Z","timestamp":1633196814000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/10\/4476\/6119358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2021,10,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab019","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,1,25]]}}}